We are thrilled to announce that Dinesh Kandanchatha has joined our team as chief information officer. Dinesh will lead IT planning for the delivery of information systems — including security and efficiency of IT operations. “Efficient, quality and compliant technology is foundational to our industry and our organization,” said Matthew Mertel, senior vice president, chief operating officer. “Dinesh brings a new perspective steeped in deep technology acumen. I’m looking forward to Dinesh joining our team and I’m confident he will challenge our thinking, push us to innovate in new ways, and positively impact our technology solutions for our health plan partners, members and stakeholders.” Welcome to the team, Dinesh! Read more: https://bit.ly/3WgSEvz
Prime Therapeutics
Insurance
Eagan, MN 56,077 followers
Helping people get the medicine they need to feel better and live well.
About us
We are reimagining pharmacy management to provide the same care we would want for our loved ones. We’re building the pharmacy solutions company of the future by leveraging our strong foundation, adapting to the evolving market and improving the way pharmacy services are provided. In the pharmacy benefits management (PBM) industry, we’re different. Formed in 1998 by two Blue Cross and Blue Shield plans, Prime has grown steadily to become the fourth-largest pharmacy benefit manager in the nation – and partner of choice for 19 Blue Plan owner clients. Because we are a privately held company owned by not-for-profit health partners, we have the rigor and freedom to remain nimble and focus on the best long-term solutions that improve health outcomes and affordability for our members, the more than 92 million people we serve through health plans, employers and government programs (i.e., Medicare and Medicaid). In addition to core PBM services, we work closely with our clients to implement the right benefit design, clinical and specialty programs, formulary and networks. A few key products: IntegratedRx® FlexAccess™ Advanced Fraud, Waste and Abuse MedsYourWay® KeepWell™ HighTouchRx® NetResults™ Specialty drug management Insights+ Join us! Prime is always looking for smart, purposeful people to join our team. We’re growing fast which means there are plenty of opportunities to advance and grow in your career. At the same time, Prime supports flexibility and offers generous PTO so you can enjoy an enviable work/life balance. We’re a privately held company -big enough to make a difference and small enough for you to have an impact. Prime’s recruiting team will only contact you via phone call or through a corporate email address. Do not respond to suspicious emails or social media messages. If you have questions or are skeptical about any follow-up communications, please contact Human Resources at 1.866.469.1257 or email [email protected]
- Website
-
http://www.primetherapeutics.com/en.html
External link for Prime Therapeutics
- Industry
- Insurance
- Company size
- 1,001-5,000 employees
- Headquarters
- Eagan, MN
- Type
- Privately Held
- Founded
- 1998
- Specialties
- Pharmacy Benefits Management
Locations
-
Primary
Eagan, MN, US
-
-
Omaha, NE, US
-
Albuquerque, NM, US
Employees at Prime Therapeutics
-
Rahul Argade
Driving growth for clients by removing tech debt and barriers | Enterprise Architect | Cloud Advisor| Organizational Lead | Executive/VP Driving…
-
Tom Cox
Software Product Developer
-
Dinesh Kandanchatha
CIO/CTO
-
Ram S.
Tech Leader, Startup Tech Advisor, DevSecOps, Angel investor
Updates
-
Discover key insights that matter to your business from the 2024 Employer Market Insights Report! Learn about the biggest trend drivers, our three-year trend forecasts and the key conditions and products you need to be watching here: https://bit.ly/3zsdi2A
-
-
85% of individuals who newly started glucagon-like peptide-1 (GLP-1) agonist drugs for weight loss were no longer taking the drug after 2 years. Read more from our recent GLP-1 real-world analysis here: https://bit.ly/3WdWkOC
-
Lifileucel is a first-in-class cellular therapy for solid tumor cancers that appears to be a promising treatment option for patients with unresectable or metastatic melanoma who are refractory to immune checkpoint inhibitors (ICI). More key insights can be found in our latest ECNI!: https://bit.ly/3xxZWBj
-
-
Specialty Summit is approaching, and you're invited to witness the future of this evolving landscape! 🙌 Register to attend this dazzling event in one of in one of the world's most electrifying cities here: https://bit.ly/3TO5NcM
-
We want to meet you, right where you are. Our pharmacy solutions are designed to seamlessly integrate into a member’s healthcare journey—because that’s what we would want for our loved ones. Watch the full video here: https://bit.ly/3W7pv5O
-
Our clinical news is your monthly source for drug information highlights and trending topics: https://bit.ly/3L5uMVc
-
-
Find your place at Prime. Join our team and help reimagine pharmacy management to provide the same care you would want for your loved ones. Learn more about the opportunities with Prime: https://bit.ly/3zjAAYp
-